PLYGF polypeptide group: Samsung Biologics announces tender offer to acquire polypeptide group Ag for chf 44.31 per share Polypeptide group

PLYGF polypeptide group: Samsung Biologics announces tender offer to acquire polypeptide group Ag for chf 44.31 per share Polypeptide group Ag - updates FY 2026 guidance to 25-30% revenue growth, high-teens EBITDA margin - H1 2026 revenue EUR 236.6M, up 41.6% year-on-year